nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—SLCO1A2—epilepsy syndrome	0.262	0.625	CbGaD
Sumatriptan—ABCG2—epilepsy syndrome	0.111	0.264	CbGaD
Sumatriptan—MAOA—Zonisamide—epilepsy syndrome	0.0708	0.36	CbGbCtD
Sumatriptan—ABCB1—epilepsy syndrome	0.0461	0.11	CbGaD
Sumatriptan—ABCB1—Levetiracetam—epilepsy syndrome	0.0263	0.133	CbGbCtD
Sumatriptan—ABCB1—Clobazam—epilepsy syndrome	0.0182	0.0925	CbGbCtD
Sumatriptan—ABCB1—Lamotrigine—epilepsy syndrome	0.0175	0.089	CbGbCtD
Sumatriptan—ABCB1—Carbamazepine—epilepsy syndrome	0.0151	0.0766	CbGbCtD
Sumatriptan—ABCB1—Phenytoin—epilepsy syndrome	0.0135	0.0687	CbGbCtD
Sumatriptan—ABCB1—Phenobarbital—epilepsy syndrome	0.0121	0.0613	CbGbCtD
Sumatriptan—ABCB1—Midazolam—epilepsy syndrome	0.0119	0.0604	CbGbCtD
Sumatriptan—ABCB1—Diazepam—epilepsy syndrome	0.0114	0.0581	CbGbCtD
Sumatriptan—HTR1D—meninx—epilepsy syndrome	0.00856	0.135	CbGeAlD
Sumatriptan—HTR3A—vagus nerve—epilepsy syndrome	0.0039	0.0617	CbGeAlD
Sumatriptan—MAOA—locus ceruleus—epilepsy syndrome	0.00315	0.0498	CbGeAlD
Sumatriptan—HTR1F—ganglion—epilepsy syndrome	0.00308	0.0487	CbGeAlD
Sumatriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00203	0.032	CbGeAlD
Sumatriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00196	0.031	CbGeAlD
Sumatriptan—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00163	0.0259	CbGeAlD
Sumatriptan—HTR3A—ganglion—epilepsy syndrome	0.0015	0.0238	CbGeAlD
Sumatriptan—DRD2—telencephalic ventricle—epilepsy syndrome	0.00148	0.0234	CbGeAlD
Sumatriptan—HTR1F—forebrain—epilepsy syndrome	0.00129	0.0204	CbGeAlD
Sumatriptan—HTR1B—ganglion—epilepsy syndrome	0.00126	0.0199	CbGeAlD
Sumatriptan—HTR1D—ganglion—epilepsy syndrome	0.00122	0.0193	CbGeAlD
Sumatriptan—HTR1F—telencephalon—epilepsy syndrome	0.00119	0.0188	CbGeAlD
Sumatriptan—HTR1A—ganglion—epilepsy syndrome	0.00102	0.0161	CbGeAlD
Sumatriptan—MAOA—ganglion—epilepsy syndrome	0.00093	0.0147	CbGeAlD
Sumatriptan—DRD2—ganglion—epilepsy syndrome	0.000919	0.0145	CbGeAlD
Sumatriptan—HTR1A—hindbrain—epilepsy syndrome	0.000772	0.0122	CbGeAlD
Sumatriptan—HTR1F—head—epilepsy syndrome	0.000739	0.0117	CbGeAlD
Sumatriptan—MAOA—hindbrain—epilepsy syndrome	0.000705	0.0112	CbGeAlD
Sumatriptan—HTR1F—nervous system—epilepsy syndrome	0.000701	0.0111	CbGeAlD
Sumatriptan—DRD2—hindbrain—epilepsy syndrome	0.000697	0.011	CbGeAlD
Sumatriptan—HTR1F—central nervous system—epilepsy syndrome	0.000675	0.0107	CbGeAlD
Sumatriptan—HTR3A—brainstem—epilepsy syndrome	0.000653	0.0103	CbGeAlD
Sumatriptan—HTR3A—forebrain—epilepsy syndrome	0.000631	0.00998	CbGeAlD
Sumatriptan—HTR3A—telencephalon—epilepsy syndrome	0.00058	0.00917	CbGeAlD
Sumatriptan—HTR1B—brainstem—epilepsy syndrome	0.000548	0.00867	CbGeAlD
Sumatriptan—HTR1F—brain—epilepsy syndrome	0.000536	0.00848	CbGeAlD
Sumatriptan—HTR1D—brainstem—epilepsy syndrome	0.000531	0.0084	CbGeAlD
Sumatriptan—HTR1B—forebrain—epilepsy syndrome	0.000529	0.00837	CbGeAlD
Sumatriptan—HTR1D—forebrain—epilepsy syndrome	0.000512	0.0081	CbGeAlD
Sumatriptan—SLCO1A2—forebrain—epilepsy syndrome	0.000498	0.00787	CbGeAlD
Sumatriptan—HTR1B—telencephalon—epilepsy syndrome	0.000486	0.0077	CbGeAlD
Sumatriptan—HTR1D—telencephalon—epilepsy syndrome	0.000471	0.00745	CbGeAlD
Sumatriptan—SLCO1A2—telencephalon—epilepsy syndrome	0.000458	0.00724	CbGeAlD
Sumatriptan—HTR1A—brainstem—epilepsy syndrome	0.000442	0.007	CbGeAlD
Sumatriptan—HTR1A—forebrain—epilepsy syndrome	0.000427	0.00675	CbGeAlD
Sumatriptan—MAOA—brainstem—epilepsy syndrome	0.000404	0.00639	CbGeAlD
Sumatriptan—DRD2—brainstem—epilepsy syndrome	0.0004	0.00632	CbGeAlD
Sumatriptan—HTR1A—telencephalon—epilepsy syndrome	0.000393	0.00621	CbGeAlD
Sumatriptan—MAOA—forebrain—epilepsy syndrome	0.00039	0.00617	CbGeAlD
Sumatriptan—DRD2—forebrain—epilepsy syndrome	0.000386	0.0061	CbGeAlD
Sumatriptan—Eletriptan—HTR7—epilepsy syndrome	0.000377	0.231	CrCbGaD
Sumatriptan—HTR3A—head—epilepsy syndrome	0.000361	0.00571	CbGeAlD
Sumatriptan—SLCO1A2—medulla oblongata—epilepsy syndrome	0.00036	0.00569	CbGeAlD
Sumatriptan—MAOA—telencephalon—epilepsy syndrome	0.000359	0.00567	CbGeAlD
Sumatriptan—DRD2—telencephalon—epilepsy syndrome	0.000355	0.00561	CbGeAlD
Sumatriptan—HTR1B—midbrain—epilepsy syndrome	0.000349	0.00553	CbGeAlD
Sumatriptan—HTR3A—nervous system—epilepsy syndrome	0.000342	0.00542	CbGeAlD
Sumatriptan—HTR1B—spinal cord—epilepsy syndrome	0.000341	0.00539	CbGeAlD
Sumatriptan—HTR1D—midbrain—epilepsy syndrome	0.000338	0.00535	CbGeAlD
Sumatriptan—HTR3A—central nervous system—epilepsy syndrome	0.00033	0.00521	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—epilepsy syndrome	0.000329	0.0052	CbGeAlD
Sumatriptan—SLCO1A2—spinal cord—epilepsy syndrome	0.000321	0.00507	CbGeAlD
Sumatriptan—ABCG2—telencephalon—epilepsy syndrome	0.000311	0.00492	CbGeAlD
Sumatriptan—HTR1B—head—epilepsy syndrome	0.000303	0.00479	CbGeAlD
Sumatriptan—Almotriptan—CYP2C19—epilepsy syndrome	0.0003	0.184	CrCbGaD
Sumatriptan—HTR1D—head—epilepsy syndrome	0.000293	0.00464	CbGeAlD
Sumatriptan—HTR1B—nervous system—epilepsy syndrome	0.000287	0.00454	CbGeAlD
Sumatriptan—SLCO1A2—head—epilepsy syndrome	0.000285	0.00451	CbGeAlD
Sumatriptan—HTR1A—midbrain—epilepsy syndrome	0.000282	0.00446	CbGeAlD
Sumatriptan—MAOA—medulla oblongata—epilepsy syndrome	0.000282	0.00446	CbGeAlD
Sumatriptan—HTR1D—nervous system—epilepsy syndrome	0.000278	0.0044	CbGeAlD
Sumatriptan—HTR1B—central nervous system—epilepsy syndrome	0.000276	0.00437	CbGeAlD
Sumatriptan—HTR1A—spinal cord—epilepsy syndrome	0.000275	0.00435	CbGeAlD
Sumatriptan—SLCO1A2—nervous system—epilepsy syndrome	0.00027	0.00427	CbGeAlD
Sumatriptan—HTR1D—central nervous system—epilepsy syndrome	0.000268	0.00423	CbGeAlD
Sumatriptan—HTR3A—brain—epilepsy syndrome	0.000262	0.00414	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—epilepsy syndrome	0.00026	0.00412	CbGeAlD
Sumatriptan—MAOA—midbrain—epilepsy syndrome	0.000258	0.00407	CbGeAlD
Sumatriptan—DRD2—midbrain—epilepsy syndrome	0.000255	0.00403	CbGeAlD
Sumatriptan—SLCO1A2—cerebellum—epilepsy syndrome	0.000254	0.00402	CbGeAlD
Sumatriptan—MAOA—spinal cord—epilepsy syndrome	0.000251	0.00397	CbGeAlD
Sumatriptan—HTR1A—head—epilepsy syndrome	0.000244	0.00387	CbGeAlD
Sumatriptan—ABCG2—medulla oblongata—epilepsy syndrome	0.000244	0.00386	CbGeAlD
Sumatriptan—Eletriptan—CYP2C19—epilepsy syndrome	0.000234	0.143	CrCbGaD
Sumatriptan—HTR1A—nervous system—epilepsy syndrome	0.000232	0.00367	CbGeAlD
Sumatriptan—MAOA—head—epilepsy syndrome	0.000223	0.00353	CbGeAlD
Sumatriptan—ABCG2—midbrain—epilepsy syndrome	0.000223	0.00353	CbGeAlD
Sumatriptan—HTR1A—central nervous system—epilepsy syndrome	0.000223	0.00353	CbGeAlD
Sumatriptan—Almotriptan—CYP2D6—epilepsy syndrome	0.000222	0.136	CrCbGaD
Sumatriptan—DRD2—head—epilepsy syndrome	0.000221	0.00349	CbGeAlD
Sumatriptan—HTR1B—brain—epilepsy syndrome	0.00022	0.00347	CbGeAlD
Sumatriptan—HTR1A—cerebellum—epilepsy syndrome	0.000218	0.00345	CbGeAlD
Sumatriptan—ABCG2—spinal cord—epilepsy syndrome	0.000218	0.00345	CbGeAlD
Sumatriptan—HTR1D—brain—epilepsy syndrome	0.000213	0.00336	CbGeAlD
Sumatriptan—MAOA—nervous system—epilepsy syndrome	0.000212	0.00335	CbGeAlD
Sumatriptan—DRD2—nervous system—epilepsy syndrome	0.000209	0.00331	CbGeAlD
Sumatriptan—SLCO1A2—brain—epilepsy syndrome	0.000207	0.00327	CbGeAlD
Sumatriptan—MAOA—central nervous system—epilepsy syndrome	0.000204	0.00322	CbGeAlD
Sumatriptan—Melatonin—CYP2C19—epilepsy syndrome	0.000203	0.124	CrCbGaD
Sumatriptan—DRD2—central nervous system—epilepsy syndrome	0.000202	0.00319	CbGeAlD
Sumatriptan—MAOA—cerebellum—epilepsy syndrome	0.000199	0.00315	CbGeAlD
Sumatriptan—DRD2—cerebellum—epilepsy syndrome	0.000197	0.00312	CbGeAlD
Sumatriptan—HTR1A—brain—epilepsy syndrome	0.000177	0.0028	CbGeAlD
Sumatriptan—Eletriptan—CYP2D6—epilepsy syndrome	0.000173	0.106	CrCbGaD
Sumatriptan—ABCG2—cerebellum—epilepsy syndrome	0.000173	0.00273	CbGeAlD
Sumatriptan—ABCB1—forebrain—epilepsy syndrome	0.000167	0.00264	CbGeAlD
Sumatriptan—MAOA—brain—epilepsy syndrome	0.000162	0.00256	CbGeAlD
Sumatriptan—DRD2—brain—epilepsy syndrome	0.00016	0.00253	CbGeAlD
Sumatriptan—ABCB1—telencephalon—epilepsy syndrome	0.000153	0.00243	CbGeAlD
Sumatriptan—ABCG2—brain—epilepsy syndrome	0.00014	0.00222	CbGeAlD
Sumatriptan—Eletriptan—ABCB1—epilepsy syndrome	0.000124	0.0758	CrCbGaD
Sumatriptan—ABCB1—medulla oblongata—epilepsy syndrome	0.00012	0.00191	CbGeAlD
Sumatriptan—ABCB1—midbrain—epilepsy syndrome	0.00011	0.00174	CbGeAlD
Sumatriptan—ABCB1—spinal cord—epilepsy syndrome	0.000107	0.0017	CbGeAlD
Sumatriptan—ABCB1—head—epilepsy syndrome	9.55e-05	0.00151	CbGeAlD
Sumatriptan—ABCB1—nervous system—epilepsy syndrome	9.05e-05	0.00143	CbGeAlD
Sumatriptan—ABCB1—central nervous system—epilepsy syndrome	8.71e-05	0.00138	CbGeAlD
Sumatriptan—ABCB1—cerebellum—epilepsy syndrome	8.52e-05	0.00135	CbGeAlD
Sumatriptan—ABCB1—brain—epilepsy syndrome	6.92e-05	0.00109	CbGeAlD
Sumatriptan—Dizziness—Felbamate—epilepsy syndrome	2.71e-05	0.000128	CcSEcCtD
Sumatriptan—Dermatitis—Vigabatrin—epilepsy syndrome	2.71e-05	0.000128	CcSEcCtD
Sumatriptan—Pruritus—Oxcarbazepine—epilepsy syndrome	2.71e-05	0.000127	CcSEcCtD
Sumatriptan—Convulsion—Pregabalin—epilepsy syndrome	2.7e-05	0.000127	CcSEcCtD
Sumatriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.7e-05	0.000127	CcSEcCtD
Sumatriptan—Headache—Vigabatrin—epilepsy syndrome	2.7e-05	0.000127	CcSEcCtD
Sumatriptan—Hypertension—Pregabalin—epilepsy syndrome	2.7e-05	0.000127	CcSEcCtD
Sumatriptan—Vomiting—Diazepam—epilepsy syndrome	2.69e-05	0.000127	CcSEcCtD
Sumatriptan—Tremor—Gabapentin—epilepsy syndrome	2.68e-05	0.000126	CcSEcCtD
Sumatriptan—Rash—Diazepam—epilepsy syndrome	2.67e-05	0.000126	CcSEcCtD
Sumatriptan—Dermatitis—Diazepam—epilepsy syndrome	2.67e-05	0.000126	CcSEcCtD
Sumatriptan—Visual impairment—Topiramate—epilepsy syndrome	2.67e-05	0.000125	CcSEcCtD
Sumatriptan—Myalgia—Pregabalin—epilepsy syndrome	2.66e-05	0.000125	CcSEcCtD
Sumatriptan—Arthralgia—Pregabalin—epilepsy syndrome	2.66e-05	0.000125	CcSEcCtD
Sumatriptan—Chest pain—Pregabalin—epilepsy syndrome	2.66e-05	0.000125	CcSEcCtD
Sumatriptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.66e-05	0.000125	CcSEcCtD
Sumatriptan—Dizziness—Zonisamide—epilepsy syndrome	2.66e-05	0.000125	CcSEcCtD
Sumatriptan—Headache—Diazepam—epilepsy syndrome	2.66e-05	0.000125	CcSEcCtD
Sumatriptan—Anxiety—Pregabalin—epilepsy syndrome	2.65e-05	0.000125	CcSEcCtD
Sumatriptan—Diarrhoea—Clonazepam—epilepsy syndrome	2.65e-05	0.000125	CcSEcCtD
Sumatriptan—Anaemia—Gabapentin—epilepsy syndrome	2.65e-05	0.000124	CcSEcCtD
Sumatriptan—Hypotension—Valproic Acid—epilepsy syndrome	2.63e-05	0.000124	CcSEcCtD
Sumatriptan—Asthenia—Carbamazepine—epilepsy syndrome	2.63e-05	0.000124	CcSEcCtD
Sumatriptan—Agitation—Gabapentin—epilepsy syndrome	2.63e-05	0.000124	CcSEcCtD
Sumatriptan—Diarrhoea—Phenytoin—epilepsy syndrome	2.63e-05	0.000124	CcSEcCtD
Sumatriptan—Discomfort—Pregabalin—epilepsy syndrome	2.63e-05	0.000124	CcSEcCtD
Sumatriptan—Nausea—Fosphenytoin—epilepsy syndrome	2.62e-05	0.000123	CcSEcCtD
Sumatriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.62e-05	0.000123	CcSEcCtD
Sumatriptan—Angioedema—Gabapentin—epilepsy syndrome	2.62e-05	0.000123	CcSEcCtD
Sumatriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.61e-05	0.000123	CcSEcCtD
Sumatriptan—Vomiting—Felbamate—epilepsy syndrome	2.61e-05	0.000123	CcSEcCtD
Sumatriptan—Dry mouth—Pregabalin—epilepsy syndrome	2.6e-05	0.000122	CcSEcCtD
Sumatriptan—Pruritus—Carbamazepine—epilepsy syndrome	2.6e-05	0.000122	CcSEcCtD
Sumatriptan—Rash—Felbamate—epilepsy syndrome	2.59e-05	0.000122	CcSEcCtD
Sumatriptan—Eye disorder—Topiramate—epilepsy syndrome	2.59e-05	0.000122	CcSEcCtD
Sumatriptan—Dermatitis—Felbamate—epilepsy syndrome	2.58e-05	0.000122	CcSEcCtD
Sumatriptan—Malaise—Gabapentin—epilepsy syndrome	2.58e-05	0.000121	CcSEcCtD
Sumatriptan—Tinnitus—Topiramate—epilepsy syndrome	2.58e-05	0.000121	CcSEcCtD
Sumatriptan—Vertigo—Gabapentin—epilepsy syndrome	2.57e-05	0.000121	CcSEcCtD
Sumatriptan—Headache—Felbamate—epilepsy syndrome	2.57e-05	0.000121	CcSEcCtD
Sumatriptan—Confusional state—Pregabalin—epilepsy syndrome	2.57e-05	0.000121	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.57e-05	0.000121	CcSEcCtD
Sumatriptan—Flushing—Topiramate—epilepsy syndrome	2.57e-05	0.000121	CcSEcCtD
Sumatriptan—Syncope—Gabapentin—epilepsy syndrome	2.57e-05	0.000121	CcSEcCtD
Sumatriptan—Dizziness—Clonazepam—epilepsy syndrome	2.56e-05	0.00012	CcSEcCtD
Sumatriptan—Nausea—Vigabatrin—epilepsy syndrome	2.56e-05	0.00012	CcSEcCtD
Sumatriptan—Vomiting—Zonisamide—epilepsy syndrome	2.55e-05	0.00012	CcSEcCtD
Sumatriptan—Oedema—Pregabalin—epilepsy syndrome	2.55e-05	0.00012	CcSEcCtD
Sumatriptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.55e-05	0.00012	CcSEcCtD
Sumatriptan—Asthenia—Lamotrigine—epilepsy syndrome	2.54e-05	0.00012	CcSEcCtD
Sumatriptan—Dizziness—Phenytoin—epilepsy syndrome	2.54e-05	0.00012	CcSEcCtD
Sumatriptan—Rash—Zonisamide—epilepsy syndrome	2.53e-05	0.000119	CcSEcCtD
Sumatriptan—Infection—Pregabalin—epilepsy syndrome	2.53e-05	0.000119	CcSEcCtD
Sumatriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	2.53e-05	0.000119	CcSEcCtD
Sumatriptan—Palpitations—Gabapentin—epilepsy syndrome	2.53e-05	0.000119	CcSEcCtD
Sumatriptan—Dermatitis—Zonisamide—epilepsy syndrome	2.53e-05	0.000119	CcSEcCtD
Sumatriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	2.53e-05	0.000119	CcSEcCtD
Sumatriptan—Nausea—Diazepam—epilepsy syndrome	2.52e-05	0.000118	CcSEcCtD
Sumatriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	2.52e-05	0.000118	CcSEcCtD
Sumatriptan—Headache—Zonisamide—epilepsy syndrome	2.52e-05	0.000118	CcSEcCtD
Sumatriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	2.51e-05	0.000118	CcSEcCtD
Sumatriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	2.51e-05	0.000118	CcSEcCtD
Sumatriptan—Angiopathy—Topiramate—epilepsy syndrome	2.51e-05	0.000118	CcSEcCtD
Sumatriptan—Pruritus—Lamotrigine—epilepsy syndrome	2.51e-05	0.000118	CcSEcCtD
Sumatriptan—Shock—Pregabalin—epilepsy syndrome	2.51e-05	0.000118	CcSEcCtD
Sumatriptan—Somnolence—Valproic Acid—epilepsy syndrome	2.51e-05	0.000118	CcSEcCtD
Sumatriptan—Immune system disorder—Topiramate—epilepsy syndrome	2.5e-05	0.000118	CcSEcCtD
Sumatriptan—Nervous system disorder—Pregabalin—epilepsy syndrome	2.5e-05	0.000118	CcSEcCtD
Sumatriptan—Cough—Gabapentin—epilepsy syndrome	2.5e-05	0.000118	CcSEcCtD
Sumatriptan—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.49e-05	0.000117	CcSEcCtD
Sumatriptan—Mediastinal disorder—Topiramate—epilepsy syndrome	2.49e-05	0.000117	CcSEcCtD
Sumatriptan—Tachycardia—Pregabalin—epilepsy syndrome	2.49e-05	0.000117	CcSEcCtD
Sumatriptan—Chills—Topiramate—epilepsy syndrome	2.48e-05	0.000117	CcSEcCtD
Sumatriptan—Convulsion—Gabapentin—epilepsy syndrome	2.48e-05	0.000117	CcSEcCtD
Sumatriptan—Skin disorder—Pregabalin—epilepsy syndrome	2.47e-05	0.000116	CcSEcCtD
Sumatriptan—Hypertension—Gabapentin—epilepsy syndrome	2.47e-05	0.000116	CcSEcCtD
Sumatriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.46e-05	0.000116	CcSEcCtD
Sumatriptan—Vomiting—Clonazepam—epilepsy syndrome	2.46e-05	0.000116	CcSEcCtD
Sumatriptan—Decreased appetite—Valproic Acid—epilepsy syndrome	2.45e-05	0.000115	CcSEcCtD
Sumatriptan—Vomiting—Phenytoin—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Rash—Clonazepam—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Dermatitis—Clonazepam—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Myalgia—Gabapentin—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Arthralgia—Gabapentin—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Chest pain—Gabapentin—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Nausea—Felbamate—epilepsy syndrome	2.44e-05	0.000115	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.43e-05	0.000114	CcSEcCtD
Sumatriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	2.43e-05	0.000114	CcSEcCtD
Sumatriptan—Fatigue—Valproic Acid—epilepsy syndrome	2.43e-05	0.000114	CcSEcCtD
Sumatriptan—Anxiety—Gabapentin—epilepsy syndrome	2.43e-05	0.000114	CcSEcCtD
Sumatriptan—Dizziness—Carbamazepine—epilepsy syndrome	2.43e-05	0.000114	CcSEcCtD
Sumatriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	2.43e-05	0.000114	CcSEcCtD
Sumatriptan—Headache—Clonazepam—epilepsy syndrome	2.42e-05	0.000114	CcSEcCtD
Sumatriptan—Rash—Phenytoin—epilepsy syndrome	2.42e-05	0.000114	CcSEcCtD
Sumatriptan—Dermatitis—Phenytoin—epilepsy syndrome	2.42e-05	0.000114	CcSEcCtD
Sumatriptan—Rash—Oxcarbazepine—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Pain—Valproic Acid—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Constipation—Valproic Acid—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Headache—Phenytoin—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Erythema—Topiramate—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Discomfort—Gabapentin—epilepsy syndrome	2.41e-05	0.000113	CcSEcCtD
Sumatriptan—Headache—Oxcarbazepine—epilepsy syndrome	2.4e-05	0.000113	CcSEcCtD
Sumatriptan—Nausea—Zonisamide—epilepsy syndrome	2.39e-05	0.000112	CcSEcCtD
Sumatriptan—Dry mouth—Gabapentin—epilepsy syndrome	2.38e-05	0.000112	CcSEcCtD
Sumatriptan—Hypotension—Pregabalin—epilepsy syndrome	2.38e-05	0.000112	CcSEcCtD
Sumatriptan—Flatulence—Topiramate—epilepsy syndrome	2.37e-05	0.000112	CcSEcCtD
Sumatriptan—Dysgeusia—Topiramate—epilepsy syndrome	2.36e-05	0.000111	CcSEcCtD
Sumatriptan—Confusional state—Gabapentin—epilepsy syndrome	2.36e-05	0.000111	CcSEcCtD
Sumatriptan—Dizziness—Lamotrigine—epilepsy syndrome	2.35e-05	0.00011	CcSEcCtD
Sumatriptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.34e-05	0.00011	CcSEcCtD
Sumatriptan—Oedema—Gabapentin—epilepsy syndrome	2.34e-05	0.00011	CcSEcCtD
Sumatriptan—Vomiting—Carbamazepine—epilepsy syndrome	2.33e-05	0.00011	CcSEcCtD
Sumatriptan—Back pain—Topiramate—epilepsy syndrome	2.33e-05	0.00011	CcSEcCtD
Sumatriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.32e-05	0.000109	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.32e-05	0.000109	CcSEcCtD
Sumatriptan—Infection—Gabapentin—epilepsy syndrome	2.32e-05	0.000109	CcSEcCtD
Sumatriptan—Muscle spasms—Topiramate—epilepsy syndrome	2.32e-05	0.000109	CcSEcCtD
Sumatriptan—Rash—Carbamazepine—epilepsy syndrome	2.31e-05	0.000109	CcSEcCtD
Sumatriptan—Dermatitis—Carbamazepine—epilepsy syndrome	2.31e-05	0.000109	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.3e-05	0.000108	CcSEcCtD
Sumatriptan—Nausea—Clonazepam—epilepsy syndrome	2.3e-05	0.000108	CcSEcCtD
Sumatriptan—Headache—Carbamazepine—epilepsy syndrome	2.3e-05	0.000108	CcSEcCtD
Sumatriptan—Shock—Gabapentin—epilepsy syndrome	2.3e-05	0.000108	CcSEcCtD
Sumatriptan—Nervous system disorder—Gabapentin—epilepsy syndrome	2.29e-05	0.000108	CcSEcCtD
Sumatriptan—Paraesthesia—Pregabalin—epilepsy syndrome	2.29e-05	0.000108	CcSEcCtD
Sumatriptan—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.29e-05	0.000108	CcSEcCtD
Sumatriptan—Nausea—Phenytoin—epilepsy syndrome	2.28e-05	0.000107	CcSEcCtD
Sumatriptan—Tachycardia—Gabapentin—epilepsy syndrome	2.28e-05	0.000107	CcSEcCtD
Sumatriptan—Dyspnoea—Pregabalin—epilepsy syndrome	2.27e-05	0.000107	CcSEcCtD
Sumatriptan—Nausea—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.000107	CcSEcCtD
Sumatriptan—Skin disorder—Gabapentin—epilepsy syndrome	2.27e-05	0.000107	CcSEcCtD
Sumatriptan—Somnolence—Pregabalin—epilepsy syndrome	2.26e-05	0.000107	CcSEcCtD
Sumatriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.26e-05	0.000106	CcSEcCtD
Sumatriptan—Tremor—Topiramate—epilepsy syndrome	2.26e-05	0.000106	CcSEcCtD
Sumatriptan—Vomiting—Lamotrigine—epilepsy syndrome	2.25e-05	0.000106	CcSEcCtD
Sumatriptan—Urticaria—Valproic Acid—epilepsy syndrome	2.24e-05	0.000105	CcSEcCtD
Sumatriptan—Rash—Lamotrigine—epilepsy syndrome	2.24e-05	0.000105	CcSEcCtD
Sumatriptan—Ill-defined disorder—Topiramate—epilepsy syndrome	2.23e-05	0.000105	CcSEcCtD
Sumatriptan—Dermatitis—Lamotrigine—epilepsy syndrome	2.23e-05	0.000105	CcSEcCtD
Sumatriptan—Abdominal pain—Valproic Acid—epilepsy syndrome	2.23e-05	0.000105	CcSEcCtD
Sumatriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	2.23e-05	0.000105	CcSEcCtD
Sumatriptan—Anaemia—Topiramate—epilepsy syndrome	2.23e-05	0.000105	CcSEcCtD
Sumatriptan—Headache—Lamotrigine—epilepsy syndrome	2.22e-05	0.000105	CcSEcCtD
Sumatriptan—Decreased appetite—Pregabalin—epilepsy syndrome	2.21e-05	0.000104	CcSEcCtD
Sumatriptan—Agitation—Topiramate—epilepsy syndrome	2.21e-05	0.000104	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.2e-05	0.000103	CcSEcCtD
Sumatriptan—Fatigue—Pregabalin—epilepsy syndrome	2.2e-05	0.000103	CcSEcCtD
Sumatriptan—Hypotension—Gabapentin—epilepsy syndrome	2.18e-05	0.000103	CcSEcCtD
Sumatriptan—Nausea—Carbamazepine—epilepsy syndrome	2.18e-05	0.000103	CcSEcCtD
Sumatriptan—Pain—Pregabalin—epilepsy syndrome	2.18e-05	0.000103	CcSEcCtD
Sumatriptan—Constipation—Pregabalin—epilepsy syndrome	2.18e-05	0.000103	CcSEcCtD
Sumatriptan—Malaise—Topiramate—epilepsy syndrome	2.17e-05	0.000102	CcSEcCtD
Sumatriptan—Vertigo—Topiramate—epilepsy syndrome	2.16e-05	0.000102	CcSEcCtD
Sumatriptan—Syncope—Topiramate—epilepsy syndrome	2.16e-05	0.000102	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.13e-05	0.0001	CcSEcCtD
Sumatriptan—Palpitations—Topiramate—epilepsy syndrome	2.13e-05	0.0001	CcSEcCtD
Sumatriptan—Loss of consciousness—Topiramate—epilepsy syndrome	2.12e-05	9.96e-05	CcSEcCtD
Sumatriptan—Nausea—Lamotrigine—epilepsy syndrome	2.11e-05	9.91e-05	CcSEcCtD
Sumatriptan—Cough—Topiramate—epilepsy syndrome	2.1e-05	9.89e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	2.1e-05	9.88e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Gabapentin—epilepsy syndrome	2.1e-05	9.87e-05	CcSEcCtD
Sumatriptan—Convulsion—Topiramate—epilepsy syndrome	2.09e-05	9.82e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.08e-05	9.8e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Gabapentin—epilepsy syndrome	2.08e-05	9.8e-05	CcSEcCtD
Sumatriptan—Hypertension—Topiramate—epilepsy syndrome	2.08e-05	9.78e-05	CcSEcCtD
Sumatriptan—Somnolence—Gabapentin—epilepsy syndrome	2.08e-05	9.77e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.08e-05	9.77e-05	CcSEcCtD
Sumatriptan—Chest pain—Topiramate—epilepsy syndrome	2.05e-05	9.65e-05	CcSEcCtD
Sumatriptan—Myalgia—Topiramate—epilepsy syndrome	2.05e-05	9.65e-05	CcSEcCtD
Sumatriptan—Arthralgia—Topiramate—epilepsy syndrome	2.05e-05	9.65e-05	CcSEcCtD
Sumatriptan—Anxiety—Topiramate—epilepsy syndrome	2.04e-05	9.61e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Gabapentin—epilepsy syndrome	2.03e-05	9.55e-05	CcSEcCtD
Sumatriptan—Discomfort—Topiramate—epilepsy syndrome	2.03e-05	9.53e-05	CcSEcCtD
Sumatriptan—Urticaria—Pregabalin—epilepsy syndrome	2.02e-05	9.52e-05	CcSEcCtD
Sumatriptan—Asthenia—Valproic Acid—epilepsy syndrome	2.02e-05	9.51e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.02e-05	9.49e-05	CcSEcCtD
Sumatriptan—Fatigue—Gabapentin—epilepsy syndrome	2.01e-05	9.48e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Pregabalin—epilepsy syndrome	2.01e-05	9.48e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Pregabalin—epilepsy syndrome	2.01e-05	9.48e-05	CcSEcCtD
Sumatriptan—Dry mouth—Topiramate—epilepsy syndrome	2.01e-05	9.43e-05	CcSEcCtD
Sumatriptan—Pain—Gabapentin—epilepsy syndrome	2e-05	9.4e-05	CcSEcCtD
Sumatriptan—Constipation—Gabapentin—epilepsy syndrome	2e-05	9.4e-05	CcSEcCtD
Sumatriptan—Pruritus—Valproic Acid—epilepsy syndrome	1.99e-05	9.38e-05	CcSEcCtD
Sumatriptan—Confusional state—Topiramate—epilepsy syndrome	1.98e-05	9.32e-05	CcSEcCtD
Sumatriptan—Oedema—Topiramate—epilepsy syndrome	1.97e-05	9.25e-05	CcSEcCtD
Sumatriptan—Infection—Topiramate—epilepsy syndrome	1.95e-05	9.19e-05	CcSEcCtD
Sumatriptan—Shock—Topiramate—epilepsy syndrome	1.93e-05	9.1e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	1.93e-05	9.07e-05	CcSEcCtD
Sumatriptan—Nervous system disorder—Topiramate—epilepsy syndrome	1.93e-05	9.07e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	1.93e-05	9.06e-05	CcSEcCtD
Sumatriptan—Thrombocytopenia—Topiramate—epilepsy syndrome	1.92e-05	9.05e-05	CcSEcCtD
Sumatriptan—Tachycardia—Topiramate—epilepsy syndrome	1.92e-05	9.03e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.91e-05	8.99e-05	CcSEcCtD
Sumatriptan—Skin disorder—Topiramate—epilepsy syndrome	1.91e-05	8.98e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	1.9e-05	8.94e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	1.88e-05	8.83e-05	CcSEcCtD
Sumatriptan—Dizziness—Valproic Acid—epilepsy syndrome	1.86e-05	8.77e-05	CcSEcCtD
Sumatriptan—Urticaria—Gabapentin—epilepsy syndrome	1.86e-05	8.73e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Gabapentin—epilepsy syndrome	1.85e-05	8.69e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Gabapentin—epilepsy syndrome	1.85e-05	8.69e-05	CcSEcCtD
Sumatriptan—Hypotension—Topiramate—epilepsy syndrome	1.84e-05	8.64e-05	CcSEcCtD
Sumatriptan—Asthenia—Pregabalin—epilepsy syndrome	1.83e-05	8.6e-05	CcSEcCtD
Sumatriptan—Pruritus—Pregabalin—epilepsy syndrome	1.8e-05	8.48e-05	CcSEcCtD
Sumatriptan—Vomiting—Valproic Acid—epilepsy syndrome	1.79e-05	8.43e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.79e-05	8.42e-05	CcSEcCtD
Sumatriptan—Rash—Valproic Acid—epilepsy syndrome	1.78e-05	8.36e-05	CcSEcCtD
Sumatriptan—Dermatitis—Valproic Acid—epilepsy syndrome	1.78e-05	8.35e-05	CcSEcCtD
Sumatriptan—Headache—Valproic Acid—epilepsy syndrome	1.77e-05	8.31e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Topiramate—epilepsy syndrome	1.76e-05	8.3e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Topiramate—epilepsy syndrome	1.75e-05	8.24e-05	CcSEcCtD
Sumatriptan—Somnolence—Topiramate—epilepsy syndrome	1.75e-05	8.22e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Pregabalin—epilepsy syndrome	1.74e-05	8.2e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	1.72e-05	8.1e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Topiramate—epilepsy syndrome	1.71e-05	8.04e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.7e-05	7.98e-05	CcSEcCtD
Sumatriptan—Fatigue—Topiramate—epilepsy syndrome	1.69e-05	7.97e-05	CcSEcCtD
Sumatriptan—Dizziness—Pregabalin—epilepsy syndrome	1.68e-05	7.93e-05	CcSEcCtD
Sumatriptan—Pain—Topiramate—epilepsy syndrome	1.68e-05	7.91e-05	CcSEcCtD
Sumatriptan—Constipation—Topiramate—epilepsy syndrome	1.68e-05	7.91e-05	CcSEcCtD
Sumatriptan—Asthenia—Gabapentin—epilepsy syndrome	1.68e-05	7.89e-05	CcSEcCtD
Sumatriptan—Nausea—Valproic Acid—epilepsy syndrome	1.67e-05	7.88e-05	CcSEcCtD
Sumatriptan—Pruritus—Gabapentin—epilepsy syndrome	1.65e-05	7.78e-05	CcSEcCtD
Sumatriptan—Vomiting—Pregabalin—epilepsy syndrome	1.62e-05	7.62e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Topiramate—epilepsy syndrome	1.62e-05	7.62e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.61e-05	7.56e-05	CcSEcCtD
Sumatriptan—Rash—Pregabalin—epilepsy syndrome	1.61e-05	7.56e-05	CcSEcCtD
Sumatriptan—Dermatitis—Pregabalin—epilepsy syndrome	1.6e-05	7.55e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Gabapentin—epilepsy syndrome	1.6e-05	7.52e-05	CcSEcCtD
Sumatriptan—Headache—Pregabalin—epilepsy syndrome	1.6e-05	7.51e-05	CcSEcCtD
Sumatriptan—Urticaria—Topiramate—epilepsy syndrome	1.56e-05	7.35e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Topiramate—epilepsy syndrome	1.55e-05	7.31e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Topiramate—epilepsy syndrome	1.55e-05	7.31e-05	CcSEcCtD
Sumatriptan—Dizziness—Gabapentin—epilepsy syndrome	1.54e-05	7.27e-05	CcSEcCtD
Sumatriptan—Nausea—Pregabalin—epilepsy syndrome	1.51e-05	7.12e-05	CcSEcCtD
Sumatriptan—Vomiting—Gabapentin—epilepsy syndrome	1.49e-05	6.99e-05	CcSEcCtD
Sumatriptan—Rash—Gabapentin—epilepsy syndrome	1.47e-05	6.93e-05	CcSEcCtD
Sumatriptan—Dermatitis—Gabapentin—epilepsy syndrome	1.47e-05	6.92e-05	CcSEcCtD
Sumatriptan—Headache—Gabapentin—epilepsy syndrome	1.46e-05	6.89e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Topiramate—epilepsy syndrome	1.45e-05	6.81e-05	CcSEcCtD
Sumatriptan—Asthenia—Topiramate—epilepsy syndrome	1.41e-05	6.63e-05	CcSEcCtD
Sumatriptan—Pruritus—Topiramate—epilepsy syndrome	1.39e-05	6.54e-05	CcSEcCtD
Sumatriptan—Nausea—Gabapentin—epilepsy syndrome	1.39e-05	6.53e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Topiramate—epilepsy syndrome	1.34e-05	6.33e-05	CcSEcCtD
Sumatriptan—Dizziness—Topiramate—epilepsy syndrome	1.3e-05	6.11e-05	CcSEcCtD
Sumatriptan—Vomiting—Topiramate—epilepsy syndrome	1.25e-05	5.88e-05	CcSEcCtD
Sumatriptan—Rash—Topiramate—epilepsy syndrome	1.24e-05	5.83e-05	CcSEcCtD
Sumatriptan—Dermatitis—Topiramate—epilepsy syndrome	1.24e-05	5.83e-05	CcSEcCtD
Sumatriptan—Headache—Topiramate—epilepsy syndrome	1.23e-05	5.79e-05	CcSEcCtD
Sumatriptan—Nausea—Topiramate—epilepsy syndrome	1.17e-05	5.49e-05	CcSEcCtD
Sumatriptan—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	4.71e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCL2—epilepsy syndrome	4.7e-06	4.4e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ABCB1—epilepsy syndrome	4.7e-06	4.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	4.7e-06	4.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	4.7e-06	4.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.69e-06	4.39e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	4.69e-06	4.38e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	4.68e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	4.68e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	4.68e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AVP—epilepsy syndrome	4.62e-06	4.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	4.61e-06	4.31e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NPY—epilepsy syndrome	4.58e-06	4.28e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	4.58e-06	4.28e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	4.55e-06	4.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SST—epilepsy syndrome	4.55e-06	4.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	4.55e-06	4.25e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	4.53e-06	4.23e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	4.52e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	4.51e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CAT—epilepsy syndrome	4.46e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	4.46e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	4.45e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	4.43e-06	4.15e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	4.42e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	4.42e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	4.42e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—OXT—epilepsy syndrome	4.42e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CRH—epilepsy syndrome	4.42e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HES1—epilepsy syndrome	4.37e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX1—epilepsy syndrome	4.37e-06	4.08e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	4.36e-06	4.08e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	4.34e-06	4.05e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.31e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	4.28e-06	4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	4.28e-06	4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	4.28e-06	4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	4.27e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.27e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.27e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.26e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	4.26e-06	3.98e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FYN—epilepsy syndrome	4.25e-06	3.98e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—FGF2—epilepsy syndrome	4.25e-06	3.97e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	4.24e-06	3.97e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—H2AFX—epilepsy syndrome	4.24e-06	3.96e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MEF2C—epilepsy syndrome	4.23e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	4.2e-06	3.93e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	4.2e-06	3.93e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	4.18e-06	3.91e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—HMOX1—epilepsy syndrome	4.18e-06	3.91e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	4.16e-06	3.89e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	4.15e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	4.14e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AGT—epilepsy syndrome	4.13e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAT—epilepsy syndrome	4.13e-06	3.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.12e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	4.11e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	4.11e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	4.1e-06	3.83e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—YWHAZ—epilepsy syndrome	4.09e-06	3.82e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—epilepsy syndrome	4.05e-06	3.79e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	4.05e-06	3.78e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NGF—epilepsy syndrome	4.04e-06	3.78e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	4.03e-06	3.77e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ABCB1—epilepsy syndrome	4.02e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	4e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	4e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	4e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SST—epilepsy syndrome	4e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	3.98e-06	3.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	3.96e-06	3.7e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	3.96e-06	3.7e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RELA—epilepsy syndrome	3.94e-06	3.69e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	3.93e-06	3.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	3.91e-06	3.66e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	3.9e-06	3.65e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	3.89e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	3.88e-06	3.63e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MTOR—epilepsy syndrome	3.87e-06	3.62e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	3.85e-06	3.6e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	3.85e-06	3.6e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AGT—epilepsy syndrome	3.83e-06	3.58e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	3.81e-06	3.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	3.8e-06	3.55e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	3.77e-06	3.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	3.76e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	3.76e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—epilepsy syndrome	3.75e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	3.75e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	3.74e-06	3.5e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX1—epilepsy syndrome	3.73e-06	3.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	3.72e-06	3.48e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	3.69e-06	3.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	3.69e-06	3.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	3.67e-06	3.44e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	3.65e-06	3.42e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	3.65e-06	3.41e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	3.61e-06	3.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	3.6e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	3.59e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	3.58e-06	3.35e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	3.58e-06	3.34e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	3.57e-06	3.34e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	3.57e-06	3.34e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	3.56e-06	3.33e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	3.56e-06	3.33e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AGT—epilepsy syndrome	3.53e-06	3.31e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	3.5e-06	3.28e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	3.5e-06	3.27e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	3.49e-06	3.27e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—epilepsy syndrome	3.48e-06	3.25e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.48e-06	3.25e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—epilepsy syndrome	3.46e-06	3.24e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	3.45e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	3.45e-06	3.22e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	3.43e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	3.43e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	3.41e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.39e-06	3.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	3.37e-06	3.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.37e-06	3.15e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	3.36e-06	3.14e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	3.36e-06	3.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	3.35e-06	3.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	3.33e-06	3.12e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	3.3e-06	3.09e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	3.29e-06	3.08e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AGT—epilepsy syndrome	3.27e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	3.26e-06	3.05e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	3.26e-06	3.05e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—epilepsy syndrome	3.22e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.21e-06	3e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—epilepsy syndrome	3.21e-06	3e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—epilepsy syndrome	3.17e-06	2.97e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	3.17e-06	2.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—S100B—epilepsy syndrome	3.17e-06	2.96e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	3.16e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	3.15e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	3.13e-06	2.93e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	3.13e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	3.1e-06	2.9e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	3.07e-06	2.87e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.05e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.04e-06	2.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AVP—epilepsy syndrome	3.03e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	3.02e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	3.01e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	3.01e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	3.01e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.98e-06	2.78e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	2.94e-06	2.75e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—epilepsy syndrome	2.94e-06	2.75e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.93e-06	2.74e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.9e-06	2.71e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.89e-06	2.71e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.88e-06	2.7e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.87e-06	2.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HES1—epilepsy syndrome	2.86e-06	2.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FYN—epilepsy syndrome	2.78e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.78e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	2.77e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	2.77e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—epilepsy syndrome	2.75e-06	2.58e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.75e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.73e-06	2.55e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.72e-06	2.55e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.72e-06	2.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	2.72e-06	2.54e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.71e-06	2.54e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TH—epilepsy syndrome	2.71e-06	2.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.68e-06	2.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.67e-06	2.49e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	2.66e-06	2.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NGF—epilepsy syndrome	2.65e-06	2.47e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.61e-06	2.44e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.57e-06	2.41e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—epilepsy syndrome	2.57e-06	2.4e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	2.52e-06	2.36e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.52e-06	2.36e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.52e-06	2.35e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—epilepsy syndrome	2.51e-06	2.35e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.51e-06	2.34e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	2.47e-06	2.31e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	2.47e-06	2.31e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	2.42e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.39e-06	2.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.39e-06	2.24e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.37e-06	2.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.34e-06	2.19e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.3e-06	2.15e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.29e-06	2.15e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2.29e-06	2.14e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	2.27e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.26e-06	2.11e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.25e-06	2.1e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.24e-06	2.1e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—epilepsy syndrome	2.23e-06	2.09e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	2.23e-06	2.08e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	2.21e-06	2.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.21e-06	2.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.2e-06	2.06e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.2e-06	2.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	2.16e-06	2.02e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	2.15e-06	2.01e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	2.1e-06	1.97e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	2.08e-06	1.95e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.04e-06	1.91e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	2.03e-06	1.89e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.02e-06	1.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.01e-06	1.88e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.98e-06	1.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.97e-06	1.84e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	1.94e-06	1.81e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.93e-06	1.8e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-06	1.8e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.89e-06	1.77e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.88e-06	1.76e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.84e-06	1.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.78e-06	1.66e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AGT—epilepsy syndrome	1.77e-06	1.65e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—epilepsy syndrome	1.73e-06	1.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.71e-06	1.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.7e-06	1.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.65e-06	1.54e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.65e-06	1.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.62e-06	1.51e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.6e-06	1.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.56e-06	1.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.5e-06	1.41e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.49e-06	1.39e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—epilepsy syndrome	1.49e-06	1.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.48e-06	1.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.45e-06	1.35e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.44e-06	1.35e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.41e-06	1.32e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.39e-06	1.3e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.37e-06	1.28e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—epilepsy syndrome	1.36e-06	1.27e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.3e-06	1.21e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—epilepsy syndrome	1.29e-06	1.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.26e-06	1.18e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.23e-06	1.15e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.21e-06	1.13e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.19e-06	1.12e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.19e-06	1.11e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.1e-06	1.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	9.19e-07	8.59e-06	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	8.07e-07	7.54e-06	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.97e-07	5.58e-06	CbGpPWpGaD
